CLINICAL_TRIALS
trial_result
· 2017-03-29
Clinical Trial Update: To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablet Under Fasting and Fed [Phase 1]
Summary
This Phase 1 trial reports the relative bioequivalence of lisinopril 40 mg tablets under fasting and fed conditions, sponsored by Sandoz.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sandoz | Conditions: Hypertension | Phase 1 | Status: COMPLETED